Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
05/06/2008 | US7368141 Precipitating casein from a product that contains lactoferrin to form a lactoferrin-casein adsorption product and subjecting the precipitate to extraction to release the lactoferrin associated with it; the extraction medium may be then subjected to different types of purification operation steps |
05/06/2008 | US7368108 Glycopeptide remodeling using amidases |
05/06/2008 | CA2451190C Process for extracting flax protein concentrate from flax meal |
05/06/2008 | CA2403190C Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis |
05/06/2008 | CA2286668C Trans-platinum compound, and diagnostic kit |
05/06/2008 | CA2283868C Photosensitizer conjugates for pathogen targeting |
05/06/2008 | CA2163637C Topologically segregated, encoded solid phase libraries |
05/06/2008 | CA2125636C Process for preparing an .alpha.-amino acid amide, useful for peptidic synthesis |
05/02/2008 | WO2008051383A2 Use of alcohol co-solvents to improve pegylation reaction yields |
05/02/2008 | WO2008051178A2 Purification of proteins with cationic surfactant |
05/02/2008 | WO2008049942A1 Enzymatic collagen hydrolysate and method for obtaining same |
05/02/2008 | WO2008049262A1 A bamboo shoot amino acid peptide extract, its preparation method and its use |
05/02/2008 | WO2007082173A3 Compositions and methods for enhancing the identification of prion protein prpsc |
05/02/2008 | CA2608923A1 Non-metallic laboratory implement and method of its use |
05/01/2008 | US20080103290 Eluting from polystyrene divinyl benzene resin using acidified solution containing organic solvent; antibacterial |
05/01/2008 | US20080103061 Functionalized compositions for improved immobilization |
04/30/2008 | EP1916256A2 Search for cancer markers by a novel screening method |
04/30/2008 | EP1915389A2 Differentially protected orthogonal lanthionine technology |
04/30/2008 | EP1915388A1 F11 receptor (f11r) antagonists as therapeutic agents |
04/30/2008 | EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
04/30/2008 | EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9; |
04/30/2008 | EP1307486B1 Somatostatin analogues |
04/30/2008 | EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
04/30/2008 | EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
04/30/2008 | EP1183360B1 Modified cytokine for its stabilisation |
04/30/2008 | EP0983351B1 Nucleic acid binding proteins |
04/30/2008 | EP0983350B1 Nucleic acid binding proteins |
04/30/2008 | CN101171261A Immunoglobulin fraction and process therefor |
04/30/2008 | CN101171022A Compositions and methods for inhibiting G protein signaling |
04/30/2008 | CN101168561A Method for separating and purifying microcystin |
04/30/2008 | CN101168559A Method for separating and purifying Chinese cabbage differential protein/isozyme |
04/30/2008 | CN100384874C Protein a chromatography |
04/30/2008 | CN100384872C Method for purifying mouse herve growth factor for scale-production |
04/30/2008 | CN100384869C Diisopropoxy phosphoryl dipeptide trimethoxy benzamide compound and its preparation process |
04/29/2008 | US7365178 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis |
04/29/2008 | US7365173 Using procainamide/peptide ligand affinity chromatography to isolate hydrolase from biological fluid |
04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
04/29/2008 | US7365168 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
04/29/2008 | US7365163 Isolation nulceic acid; genetic engineering; screening antagonist; aminobutyric acid receptor; diagnostics for detecting aberrant GABAA receptor epsilon subunit (GABRE) and ET2 expression, therapy of disorders involving ET2 and GABRE |
04/29/2008 | US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use |
04/29/2008 | US7365161 Mutant tyrosine repressor which does not require tyrosine to induce expression of the tyrosine phenol-lyase gene |
04/29/2008 | US7365160 Membrane protein for use as diagnostic tool in detection and screening of xenobiotics; drug screening |
04/29/2008 | US7365051 Compounds with improved cartilage-inducing and/or bone-inducing activity |
04/29/2008 | US7364903 Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor |
04/29/2008 | US7364896 Test strips including flexible array substrates and method of hybridization |
04/29/2008 | US7364889 Catalytically active peptides |
04/29/2008 | US7364866 Insecticides; generating immunology response |
04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
04/29/2008 | CA2242325C Fsh and lh separation and purification process |
04/24/2008 | WO2008048472A2 Methods and compositions for stabilizing prostate specific antigen |
04/24/2008 | WO2008048322A1 Mouse models to study cachexia |
04/24/2008 | WO2008046232A1 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation |
04/24/2008 | WO2008015425A3 Mhc oligomers, components thereof, and methods of making the same |
04/24/2008 | WO2007149281A3 Combinatorial library for proteomic investigations |
04/24/2008 | WO2007100506A3 Mass tags for quantitative analyses |
04/24/2008 | US20080097084 Rho Antibody And Tag To Purify Cell Surface Proteins |
04/24/2008 | US20080096812 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents |
04/24/2008 | US20080096252 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields |
04/24/2008 | US20080095914 Novel Vegetable Protein Fractionization Process And Compositions |
04/24/2008 | CA2702605A1 Unprotected amino aldehydes and applications for same |
04/24/2008 | CA2667636A1 Ssl7 mutants and uses therefor |
04/24/2008 | CA2665262A1 Method and compositions for stabilizing prostate specific antigen |
04/23/2008 | EP1914550A1 Peptide-immobilized substrate and method for measuring target protein using the same |
04/23/2008 | EP1913013A2 Truncated oxidized thymosin beta4 and derivatives thereof |
04/23/2008 | EP1791860B1 Purification process for bacterial cytolysin |
04/23/2008 | EP1659919A4 Hemostatic devices containing a protein precipitate |
04/23/2008 | EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
04/23/2008 | EP1182458B1 Method for detecting proteins under mutual interaction |
04/23/2008 | EP0906417B1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents |
04/23/2008 | CN201049218Y Protein crystallizing plate |
04/23/2008 | CN101166754A Process for preparation of mixtures of polypeptides using purified hydrobromic acid |
04/23/2008 | CN101166753A Polymer conjugates of mutated neublastin |
04/23/2008 | CN101165067A Solid phase synthesis method for adrenomedullin (27-52) |
04/23/2008 | CN100383250C Method of expressing bird catching arachinid toxin I and its special carrier |
04/23/2008 | CN100383158C Method and compositions for peptide synthesis |
04/23/2008 | CN100382717C Enhanced oil seed protein recovery |
04/22/2008 | US7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
04/22/2008 | US7361739 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
04/22/2008 | US7361735 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy |
04/22/2008 | US7361731 Lithography; ink jet printing; for drug delivery |
04/22/2008 | US7361460 Approach to molecular diagnosis of human papillomavirus-related diseases |
04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
04/22/2008 | CA2320190C A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
04/22/2008 | CA2261902C Radiolabeled annexin conjugates whith hexose and a chelator |
04/22/2008 | CA2177575C Method for purifying polypeptides |
04/17/2008 | WO2008044798A1 Agent for introducing protein into cell |
04/17/2008 | WO2008044628A1 Process for production of peptide thioester |
04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
04/17/2008 | WO2008044379A1 Bone loss model animal |
04/17/2008 | WO2008043847A1 Processing enzymes fused to basic protein tags |
04/17/2008 | WO2008043147A1 Process for generation of protein and uses thereof |
04/17/2008 | WO2008025558A3 Affinity marker comprising a first and a second tag and its use |
04/17/2008 | WO2007144077A3 Improved photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins |
04/17/2008 | WO2006119388A8 Methods for the production of peptide having a c-terminal amide |
04/17/2008 | US20080090995 Liquid Chromatography Method |
04/17/2008 | US20080090993 Recombinant cytotoxic lymphocyte-8 for use as regulator of hematopoietic cells; treating infections, allergies and cell proliferative disorders |
04/17/2008 | US20080090776 Obtained from lung cancer patients; cDNA and genomic DNA of a novel fusion polynucleotide of an EML4 gene fused with an ALK gene as kinase (EML4-ALK fusion polynucleotide variant 1); for screening a therapeutic agent for cancer, treating cancer |
04/17/2008 | US20080090282 Use of cell surface displays in yeast cell catalyst supports |
04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |